Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 20/20 | 0.51 |
| ▸ | SLC5A1 | P13866 | 8/20 | 0.49 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.46 |
| ▸ | SLC5A11 | Q8WWX8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23453206 | 0.93 | SLC5A2 (0.59) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL19676633 | 0.93 | SLC5A2 (0.59) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL19676719 | 0.93 | SLC5A2 (0.59) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL19215280 | 0.90 | SLC5A2 (0.60) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL10210912 | 0.90 | SLC5A2 (0.60) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL27913 | 0.87 | SLC5A2 (0.51) | SLC5A2SLC5A1 | |
| SCHEMBL28693 | 0.87 | SLC5A2 (0.47) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL27889 | 0.87 | SLC5A2 (0.47) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL26903 | 0.87 | SLC5A2 (0.47) | SLC5A2SLC5A1ADRA2ASLC5A11 | |
| SCHEMBL29512 | 0.86 | SLC5A2 (0.46) | SLC5A2SLC5A1ADRA2ASLC5A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021260617-A1 | AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE | HIKAL LIMITED (IN) | 2021-12-30 | — | — | WO | disclosed |